Cargando…
Critical Implications of IVDR for Innovation in Diagnostics: Input From the BioMed Alliance Diagnostics Task Force
Autores principales: | Dombrink, Isabel, Lubbers, Bart R., Simulescu, Loredana, Doeswijk, Robin, Tkachenko, Olga, Dequeker, Elisabeth, Fraser, Alan G., van Dongen, Jacques J. M., Cobbaert, Christa, Brüggemann, Monika, Macintyre, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126521/ https://www.ncbi.nlm.nih.gov/pubmed/35620593 http://dx.doi.org/10.1097/HS9.0000000000000724 |
Ejemplares similares
-
The New EU Regulation on In Vitro Diagnostic Medical Devices: Implications and Preparatory Actions for Diagnostic Laboratories
por: Lubbers, Bart R., et al.
Publicado: (2021) -
Experience With IVDR Implementation in Three Diagnostic Laboratories: Messages to EU Health Institutions, Diagnostic Healthcare Payers, and Authorities
por: Lubbers, Bart R., et al.
Publicado: (2023) -
Access to Affordable Orphan Medicines in Europe: An EHA Position Paper
por: Merlini, Giampaolo, et al.
Publicado: (2020) -
Delivering on the Promise: Innovative Therapies and the Quest for (Real) Patient Benefit
por: Doeswijk, Robin
Publicado: (2019) -
EU-Wide Access to High-quality, Affordable Precision Diagnostics: An EHA Position Paper
por: Macintyre, Elizabeth, et al.
Publicado: (2020)